Print Page  Close Window

FAQ's

1.Where do Quest Diagnostics shares of stock, bonds and options trade?
2.Who is Quest Diagnostics’ transfer agent?
3.What is book-entry and how do I keep track of my book-entry shares?
4.What is Quest Diagnostics’ dividend policy?
5.What is the next dividend payment date?
6.What is the Company's stock-split history?
7.Does Quest Diagnostics have a direct purchase plan?
8.Does Quest Diagnostics have a dividend reinvestment plan?
9.What are Quest Diagnostics' credit ratings?
10.When will you release your next quarterly results?
11.Do you have an investor relations question that’s not listed here?
1.Where do Quest Diagnostics shares of stock, bonds and options trade?
 Shares in Quest Diagnostics trade on the New York Stock Exchange under the symbol "DGX."

Fixed Income bonds trade over the counter.

Options on DGX shares are traded on the Chicago Board Options Exchange.

2.Who is Quest Diagnostics’ transfer agent?
 Our transfer agent is Computershare. They can be reached at:

Computershare
P.O. BOX 30170
College Station, TX 77842-3170
Telephone inquiries: 877-581-5548 (US, Canada, Puerto Rico)
781-575-4735 (all other locations)

Overnight correspondence should be sent to:
Computershare
211 Quality Circle, Suite 210
College Station, TX 77845

Shareholder website
www.computershare.com/investor

Shareholder online inquiries

https://www-us.computershare.com/investor/Contact

3.What is book-entry and how do I keep track of my book-entry shares?
 Book-entry form of registered ownership allows you to own shares without having paper stock certificates in your possession. You are the record owner and enjoy the same shareholder benefits as you would with certificated shares. If you have book-entry shares, you will receive a statement of your holdings on a yearly basis. You may, of course, request an additional statement at any time by contacting Computershare at 800-622-6757 (US, Canada, Puerto Rico) or 781-575-4735 (all other locations).

4.What is Quest Diagnostics’ dividend policy?
 Quest Diagnostics' Board of Directors has increased its quarterly dividend to $0.45 per share from $0.40 per share, commencing with the dividend payable January 25, 2017 to holders of record of the common stock on January 10, 2017. The dividend payment information for the four preceding quarters is as follows:

5.What is the next dividend payment date?
 The next dividend payment date is April 19, 2017 for shareholders of record as of April 5, 2017.

The dividend payment information for the four preceding quarters is as follows:


Record Date January 10, 2017 October 4, 2016 July 6, 2016 April 6, 2016
Payment Date January 25, 2017 October 19, 2016 July 20, 20166 April 20, 2016
Dividend Payment $0.45 $0.40 $0.40 $0.40

6.What is the Company's stock-split history?
 Quest Diagnostics executed two-for-one stock splits on May 31, 2001 and on June 20, 2005.

7.Does Quest Diagnostics have a direct purchase plan?
 

Yes. The plan is named the Computershare Investment Plan and it is a direct stock purchase and dividend reinvestment plan. Please direct inquiries to:

Computershare
P.O. BOX 30170
College Station, TX 77842-3170
Telephone inquiries: 877-581-5548 (US, Canada, Puerto Rico)
781-575-4735 (all other locations)

Overnight correspondence should be sent to:
Computershare
211 Quality Circle, Suite 210
College Station, TX 77845


8.Does Quest Diagnostics have a dividend reinvestment plan?
 

Yes. The plan is named the Computershare Investment Plan and it is a direct stock purchase and dividend reinvestment plan. Please direct inquiries to:

Computershare
P.O. BOX 30170
College Station, TX 77842-3170
Telephone inquiries: 877-581-5548 (US, Canada, Puerto Rico)
781-575-4735 (all other locations)

Overnight correspondence should be sent to:
Computershare
211 Quality Circle, Suite 210
College Station, TX 77845


9.What are Quest Diagnostics' credit ratings?
 Quest Diagnostics has credit rating relationships with Standard & Poor's, Moody's Investors Service and Fitch Ratings. Standard & Poor's rating is BBB+ with a stable outlook. Our Moody's current credit rating is Baa2 with a stable outlook. Our current credit rating with Fitch is BBB with a stable outlook.

10.When will you release your next quarterly results?
 Quest Diagnostics will release financial results for the fourth quarter and full year ended December 31, 2016 on January 26, 2017.

11.Do you have an investor relations question that’s not listed here?
 Contact Investor Relations